Electromyography and intensive therapy in myasthenia gravis
Ritzow, E.; Cierpka, G.; Ritzow, H.; Kwiatkowski, E.; Feyerherd, F.
Zeitschrift für Arztliche Fortbildung 69(12): 636-638
1975
ISSN/ISBN: 0044-2178 PMID: 1229153 Document Number: 92136
Document emailed within 1 workday
Related Documents
Engler, J.M.; Wihlm, J.M.; Lecoube, M.O.; Franckhauser, J.; Hentz, J.G.; Warter, J.M.; Dupeyron, J.P.; Morand, G.; Witz, J.P. 1990: Postoperative intensive care after thymectomy for myasthenia gravis Annales de Chirurgie 44(8): 628-631Szobor, A. 1989: Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients Acta Medica Hungarica 46(1): 13-21
Cruz Martinez, A.; Ferrer, M.T.; Perez Conde, M.C.; Diez Tejedor, E.; Barreiros, P.; Ribacoba, R. 1982: Diagnostic yield of single fiber electromyography and other electrophysiological techniques in myasthenia gravis. II. Jitter and motor unit fiber density studies. Clinical remission and thymectomy evaluation Electromyography and Clinical Neurophysiology 22(5): 395-417
Vincent, A.; Newsom-Davis, J. 1982: Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset Clinical and Experimental Immunology 49(2): 266-272
Cornejo Barrera, M.; Pérez Ramirez, J.L.; Pérez Mijares, R.; Neira Salaverria, F.; Damiano Rivero, A. 1977: Myasthenia gravis. Therapy Revista Clinica Espanola 144(3): 227-235
Morimoto, M.; Haginoya, K. 2016: Meet the experts: therapy of myasthenia gravis in childhood No to Hattatsu 48(2): 98-100
Morimoto, M.; Haginoya, K. 2016: Meet the experts: therapy of myasthenia gravis in childhood No to Hattatsu 48(2): 98-100
Tanaka, J.; Matsuzaki, K.; Arai, H.; Nagai, T.; Matsumoto, Y.; Okada, S. 1994: Intermittent methylprednisolone pulse therapy for myasthenia gravis in childhood No to Hattatsu 26(1): 14-19
Chu, C.C.; Huang, C.C. 1996: Low-dose intravenous immunoglobulin therapy in myasthenia gravis: a case report Zhonghua Yi Xue Za Zhi 57(3): 232-235
Li, L.; Zhang, Y.P. 1994: Therapy of experimental autoimmune myasthenia gravis in rabbits with 4-aminopyridine and 3,4-diaminopyridine Zhongguo Yao Li Xue Bao 15(4): 358-362
Marsh, D.O. 1974: Adrenal therapy for neuromuscular disease including myasthenia gravis from 1896 New York State Journal of Medicine 74(11): 1974-1976
Heininger, K.; Fateh-Moghadam, A.; Toyka, K.V.; Besinger, U.A.; Witthöft, J. 1980: Significance of acetylcholine receptor antibody in the diagnosis and therapy monitoring of myasthenia gravis La Ricerca in Clinica E in Laboratorio 10(1): 255-258
Lechin, F.; van der Dijs, B.; Pardey-Maldonado, B.; John, E.; Jimenez, V.; Orozco, B.; Baez, S.; Lechin, M.E. 2000: Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients Journal of Medicine 31(5-6): 333-361
Nau, R.; Behrends, T.; Henze, T.; Prange, H.W. 1989: Central nervous system infection caused by Aspergillus fumigatus. A complication of immunosuppressive therapy in myasthenia gravis Der Nervenarzt 60(3): 178-180
Kanzaki, M.; Obara, T.; Sasano, S.; Hikawa, Y.; Onuki, T. 2008: Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 14(2): 119-122
Tanaka, K. 2004: Myasthenia gravis Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 5): 580-585
Pirskanen, R. 1975: Myasthenia gravis Duodecim; Laaketieteellinen Aikakauskirja 91(6): 309-312
Mozai, T.; Masui, Y. 1982: Myasthenia gravis Nihon Rinsho. Japanese Journal of Clinical Medicine 40(7): 1571-1576
Téllez Zenteno, J.F.; Morales Buenrostro, L.E.; Torre Delgadillo, A. 2000: Pathogenesis of myasthenia gravis Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 52(1): 80-85
Payk, T.R. 1973: Myasthenia gravis following thymectomy Fortschritte der Medizin 91(34): 1338-1340